Device Trial Radar · NCT07272720
PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones
Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
126
Planned (sponsor's estimate)
Start
Dec 11, 2025
Primary completion
Dec 2027
Study completion Oct 2028
Sponsor
- Lead sponsor
- Storz Medical AGNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Karolinska University Hospital
- First posted
- Dec 9, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Extracorporeal shockwave lithotripsy (ESWL) is a non-invasive standard treatment for kidney stones. This study will be conducted to evaluate the effectiveness of ESWL using MODULITH® SLX-F2 with stone tracking, compared to MODULITH® SLX-F2 without stone tracking, in adult patients with kidney stones, as measured by stone-free status.
Conditions
- Kidney Stones
- Urolithiasis
Interventions
ESWL with kidney stone tracking (StorM-Track)Device
Starting ESWL on a low energy setting with stepwise ramping and at a frequency of 1.0 or 1.5 Hz. Up to a maximum of 3'500 shockwaves unless there is no stone visible in X-ray imaging. If fragments \> 4mm remain after the first ESWL treatment, a 2nd ESWL will be performed.
Standard ESWL without stone tracking (StorM-Track disabled)Device
Same treatment protocol as for the intervention group. If fragments \> 4mm remain after the first ESWL treatment, a 2nd ESWL will be performed.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Stone-free rate (SFR)Time frame: 6±2 weeks post 1st treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Karolinska University Hospital
Stockholm, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.